Raymond James & Associates ACHILLION PHARMACEUTICALS IN Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 21, 2020
SELL
N/A
-27,216 Closed
0 $0
Q4 2019

Feb 12, 2020
SELL
N/A
-54,884 Reduced 66.85%
27,216 $164,000
Q3 2019

Nov 07, 2019
BUY
N/A
13,685 Added 20.0%
82,100 $296,000
Q2 2019

Aug 06, 2019
SELL
N/A
-7,000 Reduced 9.28%
68,415 $183,000
Q1 2019

May 06, 2019
BUY
N/A
3,965 Added 5.55%
75,415 $223,000
Q4 2018

Feb 11, 2019
BUY
N/A
7,400 Added 11.55%
71,450 $114,000
Q3 2018

Nov 14, 2018
BUY
N/A
1,000 Added 1.59%
64,050 $236,000
Q2 2018

Aug 14, 2018
BUY
N/A
200 Added 0.32%
63,050 $178,000
Q1 2018

May 14, 2018
SELL
N/A
-5,600 Reduced 8.18%
62,850 $233,000
Q4 2017

Feb 14, 2018
SELL
N/A
-19,000 Reduced 21.73%
68,450 $197,000
Q3 2017

Nov 13, 2017
SELL
N/A
-12,115 Reduced 12.17%
87,450 $393,000
Q2 2017

Aug 14, 2017
BUY
N/A
99,565
99,565 $457,000
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email